Cassava Sciences Inc. (SAVA) is priced at $35.96 after the most recent trading session. At the very opening of the session, the stock price was $41.02 and reached a high price of $41.05, prior to closing the session it reached the value of $41.57. The stock touched a low price of $35.75.
Recently in News on March 23, 2021, Cassava Sciences Announces Full-year 2020 Financial Results and Business Highlights. Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced financial results for the year ended December 31, 2020 and provided business updates. Unaudited cash and cash equivalents were approximately $280 million as of February 2021. You can read further details here
Cassava Sciences Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $117.54 on 02/04/21, with the lowest value was $6.78 for the same time period, recorded on 01/04/21.
Cassava Sciences Inc. (SAVA) full year performance was 647.61%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Cassava Sciences Inc. shares are logging -69.41% during the 52-week period from high price, and 2106.13% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.63 and $117.54.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2579684 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Cassava Sciences Inc. (SAVA) recorded performance in the market was 427.27%, having the revenues showcasing 329.12% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.45B, as it employees total of 11 workers.
Specialists analysis on Cassava Sciences Inc. (SAVA)
During the last month, 0 analysts gave the Cassava Sciences Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 29.38, with a change in the price was noted +27.59. In a similar fashion, Cassava Sciences Inc. posted a movement of +329.63% for the period of last 100 days, recording 5,133,675 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for SAVA is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Trends and Technical analysis: Cassava Sciences Inc. (SAVA)
Raw Stochastic average of Cassava Sciences Inc. in the period of last 50 days is set at 17.77%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 0.75%. In the last 20 days, the company’s Stochastic %K was 4.50% and its Stochastic %D was recorded 4.46%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 427.27%. Additionally, trading for the stock in the period of the last six months notably improved by 193.55%, alongside a boost of 647.61% for the period of the last 12 months. The shares increased approximately by -19.79% in the 7-day charts and went up by -33.76% in the period of the last 30 days. Common stock shares were driven by 329.12% during last recorded quarter.